XMVE:F:F- (EUR)

ETF | Others |

Last Closing

USD 34.5

Change

-0.16 (-0.46)%

Market Cap

USD 0.01B

Volume

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.14 (-0.27%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-3.92 (-0.70%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.70 (-0.30%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-0.74 (-0.74%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+0.35 (+0.16%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.74 (-0.58%)

USD 24.77B

ETFs Containing XMVE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.58% 82% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.58% 82% B 73% C
Trailing 12 Months  
Capital Gain 7.76% 63% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.76% 61% D- 56% F
Trailing 5 Years  
Capital Gain 44.99% 49% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.99% 50% F 41% F
Average Annual (5 Year Horizon)  
Capital Gain 6.12% 57% F 57% F
Dividend Return 6.12% 53% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.98% 54% F 87% B+
Risk Adjusted Return 51.09% 53% F 66% D+
Market Capitalization 0.01B 4% F 11% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.